Christopher Whitlow to Prognosis
This is a "connection" page, showing publications Christopher Whitlow has written about Prognosis.
Connection Strength
0.120
-
Choi AR, D'Agostino RB, Farris MK, Abdulhaleem M, Hunting JC, Wang Y, Smith MR, Ruiz J, Lycan TW, Petty WJ, Cramer CK, Tatter SB, Laxton AW, White JJ, Li W, Su J, Whitlow C, Xing F, Chan MD. Genomic signature for oligometastatic disease in non-small cell lung cancer patients with brain metastases. Front Endocrinol (Lausanne). 2024; 15:1364021.
Score: 0.040
-
Helis CA, Hughes RT, Glenn CW, Lanier CM, Masters AH, Dohm A, Ahmed T, Ruiz J, Triozzi P, Gondal H, Cramer CK, Tatter SB, Laxton AW, Xing F, Lo HW, Su J, Watabe K, Wang G, Whitlow CT, Chan MD. Predictors of Adverse Radiation Effect in Brain Metastasis Patients Treated With Stereotactic Radiosurgery and Immune Checkpoint Inhibitor Therapy. Int J Radiat Oncol Biol Phys. 2020 09 01; 108(1):295-303.
Score: 0.030
-
LeCompte MC, Hughes RT, Farris M, Masters A, Soike MH, Lanier C, Glenn C, Cramer CK, Watabe K, Su J, Ruiz J, Whitlow CT, Wang G, Laxton AW, Tatter SB, Chan MD. Impact of brain metastasis velocity on neurologic death for brain metastasis patients experiencing distant brain failure after initial stereotactic radiosurgery. J Neurooncol. 2020 Jan; 146(2):285-292.
Score: 0.029
-
Wintermark M, Sanelli PC, Anzai Y, Tsiouris AJ, Whitlow CT. Imaging evidence and recommendations for traumatic brain injury: advanced neuro- and neurovascular imaging techniques. AJNR Am J Neuroradiol. 2015 Feb; 36(2):E1-E11.
Score: 0.021